Citation: Dachuan Qi, Lei Xing, Lijun Shen, Wenshuang Sun, Cheng Cai, Chunhua Xue, Xuwei Song, Hua Yu, Hulin Jiang, Chengjun Li, Qingri Jin, Zhiqi Zhang. A GSH-depleted platinum(Ⅳ) prodrug triggers ferroptotic cell death in breast cancer[J]. Chinese Chemical Letters, ;2022, 33(10): 4595-4599. doi: 10.1016/j.cclet.2022.03.105 shu

A GSH-depleted platinum(Ⅳ) prodrug triggers ferroptotic cell death in breast cancer

Dachuan Qi ^{a, 1} ,
Lei Xing ^{b, 1} ,
Lijun Shen ^{b, 1} ,
Wenshuang Sun ^{d, 1} ,
Cheng Cai ^a ,
Chunhua Xue ^a ,
Xuwei Song ^a ,
Hua Yu ^a ,
Hulin Jiang ^{b, *,} ,
Chengjun Li ^{d, *,} ,
Qingri Jin ^{c, *,} ,
Zhiqi Zhang ^{a, *,}

a.
Department of General Surgery, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai 200434, China
b.
Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China
c.
Key Laboratory of Applied Technology on Green-Eco-Healthy Animal Husbandry of Zhejiang Province, College of Animal Science and Technology, College of Veterinary Medicine, Zhejiang A & F University, Lin'an 311300, China
d.
Department of Orthopedics, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China

jianghulin3@gmail.com

Received Date: 1 September 2021
Revised Date: 28 March 2022
Accepted Date: 29 March 2022
Available Online: 4 April 2022

Figures(3)

Cisplatin is the first-line drug for treatment of various solid tumors including breast cancer due to the broad anti-tumor spectrum and strong anti-tumor effect. However, serious side effects and long-term medication of reduced sensitivity by high GSH in tumor cells have severely restricted its further clinical application. Herein, a GSH-depleted Pt(Ⅳ) prodrug (Platin B) based on cisplatin and 4-carboxylphenylboronic acid pinacol ester was prepared to solve the problems. As an excellent GSH scavenger, 4-carboxylphenylboronic acid pinacol ester could be activated by intracellular redox reactions to release quinone methide, thereby amplifying oxidative stress and leading to breast cancer ferroptosis therapy. Interestingly, the consumption of GSH can also reduce cisplatin inactivation, enhance the sensitivity of tumor cells to cisplatin and efficiently induce apoptosis/ferroptosis. This work highlights the use of GSH scavenger for triggering ferroptotic cell death in breast cancer.
- Cisplatin,
- Ferroptosis,
- Cancer therapy,
- Glutathione depletion,
- Tetravalent platinum prodrug
1. [1]
  T.C. Johnstone, K. Suntharalingam, S.J. Lippard, Chem. Rev.116 (2016) 3436-3486. doi: 10.1021/acs.chemrev.5b00597
2. [2]
  B. Rosenberg, L. Vancamp, T. Krigas, Nature 205 (1965) 698-699. doi: 10.1038/205698a0
3. [3]
  N.J. Wheate, S. Walker, G.E. Craig, et al., Dalton Trans. 39 (2010) 8113-8127. doi: 10.1039/c0dt00292e
4. [4]
  G.Y. Ho, N. Woodward, J.I. Coward, Crit. Rev. Oncol. Hematol. 102 (2016) 37-46. doi: 10.1016/j.critrevonc.2016.03.014
5. [5]
  R.T. Penson, D.S. Dizon, S.A. Cannistra, et al., J. Clin. Oncol. 28 (2010) 154-159. doi: 10.1200/JCO.2009.22.7900
6. [6]
  J. Graham, M. Muhsin, P. Kirkpatrick, Nat. Rev. Drug Discovery 3 (2004) 11-12. doi: 10.1038/nrd1287
7. [7]
  J. Welink, E. Boven, J.B. Vermorken, et al., Clin. Cancer Res. 5 (1999) 2349-2358.
8. [8]
  I. Muhammad, A. Wagma, Coord. Chem. Rev. 376 (2018) 405-429. doi: 10.1016/j.ccr.2018.08.009
9. [9]
  J.J. Wilson, S.J. Lippard, Chem. Rev. 45 (2014) 4470-4495. doi: 10.1021/cr4004314
10. [10]
  M. Patra, S.G. Awuah, S.J. Lippard, J. Am. Chem. Soc. 138 (2016) 12541-12551. doi: 10.1021/jacs.6b06937
11. [11]
  L. Xiang, J.S. Tu, J.Q. Wang, et al., ACS Nano 13 (2019) 357-370. doi: 10.1093/forestry/cpz006
12. [12]
  L. Xiang, C. Xing, T. Wei, et al., Nano Lett. 18 (2018) 4618-4625. doi: 10.1021/acs.nanolett.8b01924
13. [13]
  S.J. Dixon, K.M. Lemberg, M.R. Lamprecht, et al., Cell 149 (2012) 1060-1072. doi: 10.1016/j.cell.2012.03.042
14. [14]
  F.R. Brigelius, M. Maiorino, Biochim. Biophys. Acta 1830 (2013) 3289-3303. doi: 10.1016/j.bbagen.2012.11.020
15. [15]
  W.S. Yang, R. Sriramaratnam, M.E. Welsch, et al., Cell 156 (2014) 317-331. doi: 10.1016/j.cell.2013.12.010
16. [16]
  J. Guo, B. Xu, Q. Han, et al., Cancer Res. Treat. 50 (2017) 445-460.
17. [17]
  Z. Shen, J. Song, B. C. Yung, et al., Adv. Mater. 30 (2018) e1704007. doi: 10.1002/adma.201704007
18. [18]
  Y.J. He, X.Y. Liu, L. Xing, et al., Biomaterials 241 (2020) 119911. doi: 10.1016/j.biomaterials.2020.119911
19. [19]
  C.Q. Luo, Y.X. Zhou, T.J. Zhou, et al., J. Control. Release 274 (2018) 56-68. doi: 10.1016/j.jconrel.2018.01.034
20. [20]
  C.A. Blencowe, A.T. Russell, F. Greco, et al., Polym. Chem. 2 (2011) 773-790. doi: 10.1039/C0PY00324G
21. [21]
  E.L. Weaver, R.N. Bose, J. Inorg. Biochem. 95 (2003) 231-239. doi: 10.1016/S0162-0134(03)00136-3
22. [22]
  R.K. Pathak, S. Marrache, J.H. Choi, et al., Angew. Chem. Int. Ed. 53 (2014) 1963-1967. doi: 10.1002/anie.201308899
23. [23]
  Q. Cheng, H. Shi, H. Wang, et al., Chem. Commun. 50 (2014) 7427-7430. doi: 10.1039/C4CC00419A
24. [24]
  Y. Zhu, L. Xing, X. Zheng, et al., Int. J. Pharm. 573 (2020) 118736. doi: 10.1016/j.ijpharm.2019.118736
25. [25]
  L. Xing, X. Chang, D. Zhao, et al., J. Control. Release331 (2021) 460-471. doi: 10.1016/j.jconrel.2021.01.037
26. [26]
  C.X. Yang, L. Xing, X. Chang, et al., Mol. Pharm. 17 (2020) 1300-1309. doi: 10.1021/acs.molpharmaceut.9b01318
27. [27]
  T.J. Zhou, L. Xing, Y.T. Fan, et al., J. Control. Release 309 (2019) 82-93. doi: 10.1016/j.jconrel.2019.07.028
28. [28]
  T.J. Zhou, L. Xing, Y.T. Fan, et al., J. Control. Release 307 (2019) 44-54. doi: 10.1016/j.jconrel.2019.06.016
29. [29]
  Y.T. Fan, T.J. Zhou, P.F. Cui, et al., Adv. Funct. Mater. 29 (2019) 1806708. doi: 10.1002/adfm.201806708
1. [1]
  Wenjia Wang , Xingyue He , Xiaojie Wang , Tiantian Zhao , Osamu Muraoka , Genzoh Tanabe , Weijia Xie , Tianjiao Zhou , Lei Xing , Qingri Jin , Hulin Jiang . Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108656-. doi: 10.1016/j.cclet.2023.108656
2. [2]
  Linjie Ju , Zhongxi Huang , Qian Shen , Chan Fu , Shuanghe Li , Wenjie Duan , Chenfeng Xu , Weizhen An , Zhiqiang Zhai , Jifu Wei , Changmin Yu , Guoren Zhou . Glutathione depletion based Pt(Ⅳ) hybrid mesoporous organosilica delivery system to conquer cisplatin chemoresistance: A “one stone three birds” strategy. Chinese Chemical Letters, 2024, 35(10): 109450-. doi: 10.1016/j.cclet.2023.109450
3. [3]
  Lin Li , Bingjun Sun , Jin Sun , Lin Chen , Zhonggui He . Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy. Chinese Chemical Letters, 2024, 35(10): 109538-. doi: 10.1016/j.cclet.2024.109538
4. [4]
  Guanghui Lin , Jieyao Chen , Xiaojia Liu , Yitong Lin , Xudong Zhu , Guotao Yuan , Bowen Yang , Shuanshuan Guo , Yue Pan , Jianhua Zhou . Sustained modulation of tumor microenvironment via sorafenib-loaded mesoporous ferromanganese nanozymes for enhanced apoptosis-ferroptosis cancer therapy. Chinese Chemical Letters, 2025, 36(8): 111018-. doi: 10.1016/j.cclet.2025.111018
5. [5]
  Yuequan Wang , Congtian Wu , Chengcheng Feng , Qin Chen , Zhonggui He , Shenwu Zhang , Cong Luo , Jin Sun . Spatiotemporally-controlled supramolecular hybrid nanoassembly enabling ferroptosis-augmented photodynamic immunotherapy of cancer. Chinese Chemical Letters, 2025, 36(3): 109902-. doi: 10.1016/j.cclet.2024.109902
6. [6]
  Linping Zhao , Jianqiao Li , Guangmiao Chen , Chuyu Huang , Hangyu Zhou , Rongrong Zheng , Youqin Xu , Xueyan Jiang , Xiaohui Chen , Shiying Li . Cuproptosis amplifier of copper-telaglenastat coordinate to trigger cell ferroptosis for synergistic breast cancer suppression. Chinese Chemical Letters, 2026, 37(1): 110959-. doi: 10.1016/j.cclet.2025.110959
7. [7]
  Zhendong Liu , Sainan Liu , Bin Liu , Qi Meng , Meng Yuan , Chunzheng Yang , Yulong Bian , Ping'an Ma , Jun Lin . Fe(Ⅲ)-juglone nanoscale coordination polymers for cascade chemodynamic therapy through synergistic ferroptosis and apoptosis strategy. Chinese Chemical Letters, 2024, 35(11): 109626-. doi: 10.1016/j.cclet.2024.109626
8. [8]
  Ru Ding , Chunfei Wang , E Lv , Jingjing Zhao , Xucong Zhou , Yuanyi Li , Ying Wang , Bingxue Li , Lixia Zhang , Jin Zhou . A near-infrared fluorescent probe based on Au³⁺/Pd²⁺ complexes for glutathione sensing: Applications in acute liver injury, hepatocellular carcinoma, and ferroptosis exploration. Chinese Chemical Letters, 2025, 36(11): 111497-. doi: 10.1016/j.cclet.2025.111497
9. [9]
  Qiuyue Lu , Min Shan , Jiaqi Yang , Zhongren Xu , Yueyue Lei , Wukun Liu . A dinuclear gold(I) complex with bis(N-heterocyclic carbene) ligands potentiated immune responses against liver cancer via ROS-driven endoplasmic reticulum stress and ferroptosis. Chinese Chemical Letters, 2025, 36(12): 110940-. doi: 10.1016/j.cclet.2025.110940
10. [10]
  Yizhi Ge , Jiahui Zou , Hui Liu , Wei He , Huanfeng Zhu . Cisplatin-polyphenol complex liposomes reduce chemotherapy toxicity. Chinese Chemical Letters, 2026, 37(1): 111450-. doi: 10.1016/j.cclet.2025.111450
11. [11]
  Huiyang Chen , Zibo Li , Xiaoying Li , Chenhong Tang , Xiaoyu Liu , Minyi Nie , Ying Huang , Xiaoyu Chen , Kuncai Liu , Yilan Dai , Qiaoling Zhang , Ling Lin , Siming Zhang , Bingchen Zhang , Zhiqiang Yu . A novel mitochondria-targeted nanoprodrug amplifies oxidative stress to enhance cisplatin chemotherapy for the treatment of hepatocellular carcinoma. Chinese Chemical Letters, 2025, 36(10): 111313-. doi: 10.1016/j.cclet.2025.111313
12. [12]
  Menglin Zhang , Fanpeng Ran , Yun Zhang , Xiaoli Zhang , Zhigang Xu , Xiaoxiao Shi . Cyclodextrin-based nanotherapeutics: A promising strategy for enhanced cancer therapy. Chinese Chemical Letters, 2026, 37(1): 111232-. doi: 10.1016/j.cclet.2025.111232
13. [13]
  Zhaoyong Kang , Shen Li , Yan Li , Jingfeng Song , Yangrui Peng , Yihua Chen . Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024). Chinese Chemical Letters, 2025, 36(7): 110447-. doi: 10.1016/j.cclet.2024.110447
14. [14]
  Hao Hu , Jiacheng Wang , Si Zhang , Ben Zhang , Cuinan Jiang , Hong Tian , Xunxin Gu , Yang Sheng , Zhenghuan Zhao , Meng Li , Lu Zheng , Jing Li . Hierarchical and flexible electrode with precise H₂-production for in vivo liver cancer therapy. Chinese Chemical Letters, 2025, 36(12): 110866-. doi: 10.1016/j.cclet.2025.110866
15. [15]
  Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
16. [16]
  Yanjun Cai , Yong Jiang , Yu Chen , Erzhuo Cheng , Yuan Gu , Yuwei Li , Qianqian Liu , Jian Zhang , Jifang Liu , Shisong Han , Bin Yang . Amplifying STING activation and immunogenic cell death by metal-polyphenol coordinated nanomedicines for enhanced cancer immunotherapy. Chinese Chemical Letters, 2025, 36(5): 110437-. doi: 10.1016/j.cclet.2024.110437
17. [17]
  Shengyi Gong , Guoqiang Feng . Visible light-triggered NIR ratiometric fluorescent metal-free CO-releasing molecule for self-monitoring of CO delivery and effective cancer therapy. Chinese Chemical Letters, 2025, 36(7): 110409-. doi: 10.1016/j.cclet.2024.110409
18. [18]
  Xin Li , Fei Xiong , Xudong Cao , Wei Liu , Haobo Chen , Jiayu He , Weina Zhang , Longguang Tang , Wei Huang , Xikuang Yao . CD44-targeting and ZIF-8 gated gold nanocage for programmed breast cancer therapy through Pt-induced immunogenic cell death. Chinese Chemical Letters, 2026, 37(1): 110970-. doi: 10.1016/j.cclet.2025.110970
19. [19]
  Yan Gao , Zi-Lin Song , Shuang Yu , Xiu-Li Zhao , Da-Wei Chen , Ming-Xi Qiao . Enhanced ferroptosis by a nanoparticle mimicking hemoglobin coordinate pattern with self-supplying hydrogen peroxide. Chinese Chemical Letters, 2025, 36(5): 110097-. doi: 10.1016/j.cclet.2024.110097
20. [20]
  Quan Lu , Lulu Zhang , Zihan Chen , Jiajia Lv , Jie Gao , Xinmin Li , Hongyu Li , Wen Shi , Xiaohua Li , Huimin Ma , Zeli Yuan . A lipid droplet-targeting fluorescence probe for monitoring of lipid peroxidation in ferroptosis and non-alcoholic fatty liver disease. Chinese Chemical Letters, 2025, 36(8): 110620-. doi: 10.1016/j.cclet.2024.110620

Get Citation

PDF

XML

Metrics

PDF Downloads(8)
Abstract views(2490)
HTML views(202)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142